Aquestive Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Aquestive Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.58M, a 104% increase year-over-year.
  • Aquestive Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.62M, a 127% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.69M, a 38.6% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.38M, a 35.8% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.82M, a 3.62% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.69M -$1.69M -38.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $4.38M -$2.44M -35.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $6.82M +$238K +3.62% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $6.58M -$490K -6.93% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $7.07M -$22.9M -76.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $29.9M +$29.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.